iX Biopharma Expands Capital with New Shares and Warrants

iX Biopharma Ltd. (SG:42C) has released an update.

iX Biopharma Ltd. has successfully completed the issuance of 115,018,984 Rights Shares and 57,509,492 Warrants, increasing its total issued and paid-up share capital. The new Rights Shares will be on par with existing shares, excluding certain dividends or distributions. Trading of these Rights Shares and Warrants on the Catalist is expected to commence around the 23rd and 24th of July 2024, respectively.

For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.